• Fund Type: Closed-End Fund
  • Objective: Blend Large Cap
  • Asset Class: Equity
  • Geographic Focus: U.S.

Nuveen Equity Premium and Growth Fund

+ Add to Watchlist

XJPGX:US

15.68 USD 0.05 0.32%

As of 09:29:30 ET on 09/12/2014.

Snapshot for Nuveen Equity Premium and Growth Fund (XJPGX)

Year To Date: +5.09% 3-Month: +1.92% 3-Year: +14.21% 52-Week Range: 14.92 - 16.01
1-Month: +1.85% 1-Year: +11.19% 5-Year: +11.59% Beta vs SPX: 0.75

Mutual Fund Chart for XJPGX

No chart data available.
  • XJPGX:US 15.68
  • 1M
  • 1Y
Interactive XJPGX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XJPGX

Nuveen Equity Premium and Growth Fund is a diversified, closed-end management investment company incorporated in the USA. The Fund's objective is to provide a high level of current income and gains from net index option premiums, as well as capital appreciation. The Fund will invests in a diversified equity portfolio that seeks to replicate price movements of the S&P 500.

Inception Date: 11-23-2005 Telephone: 1-312-917-7700
Managers: J PATRICK ROGERS
Web Site: www.nuveen.com

Fundamentals for XJPGX

NAV (on 2014-09-12) 15.68
Assets (M) (on 2014-09-12) 253.35
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for XJPGX

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-09-11) 0.26
Dividend Yield (ttm) 6.78

Fees & Expenses for XJPGX

Front Load -
Back Load -
Current Mgmt Fee -
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for XJPGX

Filing Date: 07/31/2014
Name Position Value % of Total
Apple Inc 93,201 8,907,220 3.545%
Exxon Mobil Corp 65,008 6,431,892 2.559%
Microsoft Corp 116,985 5,049,073 2.009%
Johnson & Johnson 46,221 4,626,260 1.841%
Wells Fargo & Co 78,213 3,981,042 1.584%
JPMorgan Chase & Co 64,689 3,730,615 1.485%
Chevron Corp 27,692 3,578,914 1.424%
Berkshire Hathaway Inc 27,775 3,483,818 1.386%
Gilead Sciences Inc 35,792 3,276,758 1.304%
Merck & Co Inc 56,106 3,183,454 1.267%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil